Clinical Trial Update: A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2% [Phase 2]

View source ↗

Summary

A Phase 2 study of brinzolamide 1% / brimonidine 0.2% fixed combination and its individual components in open-angle glaucoma and ocular hypertension completed, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Alphagan (brimonidine)
• Azopt (brinzolamide)
• Simbrinza (brinzolamide/brimonidine)

Snippet

Sponsor: Alcon Research | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2013-07-08